Navigation Links
Cyberonics to Present at Canaccord Adams 29th Annual Global Growth Conference
Date:8/6/2009

HOUSTON, Aug. 6 /PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX) today announced that Greg Browne, Chief Financial Officer, will present at the Canaccord Adams 29th Annual Global Growth Conference in Boston on Thursday, August 13, 2009 at 10:00 AM EDT. Presentation slides will be available on-line at www.cyberonics.com by 8:00 AM EDT on Thursday, August 13, 2009. Canaccord Adams will host a webcast of the presentation live and by replay at http://www.wsw.com/webcast/canaccord/cybx/. The replay will be available for 90 days following the conference. The presentation can also be accessed at www.cyberonics.com by clicking on the link for this webcast. Access to the webcast is not password protected.

About Cyberonics, Inc. and VNS Therapy(TM)

Cyberonics, Inc. (NASDAQ: CYBX) is a medical technology company with core expertise in neuromodulation. The company developed and markets the Vagus Nerve Stimulation (VNS) Therapy(TM) System, which is FDA-approved for the treatments of refractory epilepsy and treatment-resistant depression. The VNS Therapy System uses a surgically implanted medical device that delivers pulsed electrical signals to the vagus nerve. Cyberonics markets the VNS Therapy System in selected markets worldwide.

Additional information on Cyberonics, Inc. and VNS Therapy(TM) is available at www.cyberonics.com and www.vnstherapy.com.

    CONTACT INFORMATION:
    Greg Browne, CFO
    Cyberonics, Inc.
    100 Cyberonics Blvd.
    Houston, TX 77058
    Main:  (281) 228-7262
    Fax:  (281) 218-9332
    ir@cyberonics.com


'/>"/>
SOURCE Cyberonics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 First Quarter Financial Results
2. Cyberonics Announces Exclusive Distribution Agreement With Nihon Kohden in Japan
3. Cyberonics Names Bryan D. Olin, Ph.D. Vice President, Quality
4. Cyberonics Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2009 Financial Results
5. Cyberonics Continues Strong Sales Growth and Profitability in Fiscal 2009 Third Quarter
6. Cyberonics Announces Conference Call to Discuss Fiscal Year 2009 Third Quarter Financial Results
7. Cyberonics Names Milton M. Morris, Ph.D. Vice President, Research & Development
8. Cyberonics to Present at Piper Jaffray 20th Annual Health Care Conference
9. Cyberonics Reports Strong Sales Growth and Profitability in Fiscal 2009 Second Quarter
10. Cyberonics Announces Conference Call to Discuss Fiscal Year 2009 Second Quarter Financial Results
11. Cyberonics Provides Business Update Based on Final Ambulatory Payment Classification Rate Change Announcement by CMS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating to ... of individuals in the United States and Canada wear eyeglasses. Once considered to be ... vision and make a fashion statement. Even celebrities use glasses as a way of ...
(Date:6/26/2016)... Viejo, California (PRWEB) , ... June 26, 2016 , ... ... Final Cut Pro X. , "Film editors can give their videos a whole new ... said Christina Austin - CEO of Pixel Film Studios. , ProSlice Levels contains ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women ... diagnosed with endometriosis. These women need a treatment plan to not only alleviate ... that can help for preservation of fertility and ultimately achieving a pregnancy. The ...
(Date:6/25/2016)... ... ... The temporary closing of Bruton Memorial Library on June 21 due to a possible lice ... overlooked aspect of head lice: the parasite’s ability to live away from a human host, ... a necessary one in the event that lice have simply gotten out of control. , ...
(Date:6/25/2016)... CA (PRWEB) , ... June 25, 2016 , ... As ... with Magna Cum Laude and his M.D from the David Geffen School of Medicine ... and returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... RIDGE, Ill. and INDIANAPOLIS ... of students receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship ... The 2016 scholarship winners, announced today online at ... to let type 1 diabetes stand in the way ... Diabetes has supported the Foundation,s scholarship program since 2012, ...
(Date:6/23/2016)... 2016 The vast majority of dialysis patients ... Treatments are usually 3 times a week, with treatment ... travel time, equipment preparation and wait time.  This regimen ... for patients who are elderly and frail.  Many elderly ... rehabilitation centers for some duration of time. ...
Breaking Medicine Technology: